Table 1 Demographic and clinical characteristics of RA patients.

From: Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis

Age (years) (mean ± SD)

52.38 ± 14.21

Comorbidities (n (%))

 Diabetes

8 (13.8)

 Hypertension

18 (31)

 Dyslipidemia

37 (63.8)

 Overweight or obesity

35 (60.5)

Characteristics of RA

 Age of onset (years)

41[30.14;51.00]ª

 Duration of disease (years)

10.41[3.16;16.11]ª

 Duration of disease > 10 years (n (%))

30(52)

 DAS28-CRP

4.03[2.95;5.28]ª

 Presence of tender joints (n (%))

50 (86)

 NTJ

6 [2;10]ª

 Presence of swollen joints (n (%))

49 (85)

 NSJ

4 [2;7]ª

 VAS

5 [3;7]ª

 Presence of morning stiffness (n (%))

36(62)

 Duration of morning stiffness (minutes)

60[30;120]ª

 Presence of nocturnal awakening (n (%))

35(60)

 Number of nocturnal awakenings

2 [2;3]ª

 HAQ

1.34[0.97;1.50]ª

 Functional disability (n (%))

34(92)

 Structural damage (n (%))

39(66)

 CRP (mg/L)

8.38 [2.23;21.52]ª

 Positive RF (n (%))

46(87)

 Positive ACPA (n (%))

36(73)

  1. SD, Standard deviation; n, Number; RA, Rheumatoid arthritis; DAS28, Disease activity score; NTJ, Number of tender joints; NSJ, Number of swollen joints; VAS, Visual analog scale; HAQ, Health Assessment Questionnaire; CRP, C-reactive protein; RF, Rheumatoid factor; ACPA, Anti-citrullinated protein antibodies. ª: Median [interquartile range].